Figure 2.

Binding pose of ligand molecules of selected (prodigiosin and cycloprodigiosin) and standard (cellecoxib and rofecoxib) with different COX-2 protein (Docking of ligand into the binding pocket of inflammatory proteins establishing interactions with the active site default colors).